Embed Size (px)
DESCRIPTION
http://cordadvantage.com | Americord is happy to announce that the trademark case brought on by their rival Cord Blood Registry (CBR Systems Inc.) has been resolved. The details of why can be found in this document.
Citation preview
Contact: Andrew Flook Americord Registry 866-503-6005 [email protected]
Cord Blood Registry Withdraws Opposition to Americord’s Trademark
New York – March 16, 2014 – Americord announced today that it has successfully resolved a trademark
case brought by rival cord blood bank Cord Blood Registry (or CBR Systems Inc). In the case, which was
brought before the Trademark Trial And Appeal Board of the United States Patent and Trademark Office
last year, CBR opposed Americord Registry’s use of the trademark CordAdvantage. “We are pleased that CBR has withdrawn its opposition to Americord’s use of the trademark
CordAdvantage,” said Martin Smithmyer, President and CEO of Americord. “We felt confident from the
beginning that we had the right to use the CordAdvantage trademark, however, the process of defending a
trademark can be a challenge, and we are glad to have it resolved.” CordAdvantage refers to a specific product that Americord is developing under the direction of the
company’s Executive Medical Director Dr. Robert Dracker. Currently in the late stages of development,
CordAdvantage will utilize a proprietary process to maximize the volume of stem cells that can be
harvested from cord blood found in the placenta immediately following the birth of a baby. Americord filed the CordAdvantage trademark nearly two years ago. It has been an integral part of
Americord’s brand identity since the company’s inception. About Americord
Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta
tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood
for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as
sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in
all 50 states. The company’s laboratory is CLIA Certified, accredited by the AABB and complies with all
federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You
may visit Americord’s cord blood blog or website at cordadvantage.com for more information. You may
also find Americord on Facebook and follow the company on Twitter.
